Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
17.93
+0.29 (1.64%)
May 21, 2026, 3:00 PM CST

SHA:600079 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
23,88223,91825,38624,44522,27620,510
Other Revenue
43.7643.7649.3679.8461.6738.69
23,92623,96225,43524,52522,33820,549
Revenue Growth (YoY)
-5.08%-5.79%3.71%9.79%8.71%-0.63%
Cost of Revenue
12,35712,43514,12313,30212,63211,777
Gross Profit
11,56911,52711,31211,2239,7068,772
Selling, General & Admin
6,1626,1956,5636,1685,8275,327
Research & Development
1,4511,5011,4711,462966.86810.47
Other Operating Expenses
204.88212.6140.36202.61205.86224.56
Operating Expenses
7,8657,9568,2997,9047,0576,411
Operating Income
3,7053,5713,0143,3192,6492,361
Interest Expense
-271.04-271.04-351.37-354.14-476.57-602.15
Interest & Investment Income
124.31127.63185.18265.56978.8365.38
Currency Exchange Gain (Loss)
-30.92-30.92-23.245.96123.67-58.34
Other Non Operating Income (Expenses)
-67.4-52.11-186.88-130.81120.33-59.2
EBT Excluding Unusual Items
3,4603,3452,6373,1463,3952,007
Impairment of Goodwill
-332.06-332.06-206.98-26.15-35.33-42.68
Gain (Loss) on Sale of Investments
11.8511.8250.08136.8543.427.89
Gain (Loss) on Sale of Assets
51.0752.75-16.29-4.14-51.5126.06
Asset Writedown
-62.57-62.44-104.2-24.72-36.4-7.17
Other Unusual Items
41.4341.4362.91156.13110.86182.16
Pretax Income
3,1693,0562,4233,3843,4262,173
Income Tax Expense
605.33564644.49568.56354.75354.78
Earnings From Continuing Operations
2,5642,4921,7782,8153,0711,818
Minority Interest in Earnings
-660.74-637.12-448.6-680.78-587.19-501.05
Net Income
1,9031,8551,3302,1342,4841,317
Net Income to Common
1,9031,8551,3302,1342,4841,317
Net Income Growth
37.54%39.53%-37.70%-14.07%88.60%30.96%
Shares Outstanding (Basic)
1,6271,6271,6221,6171,6131,587
Shares Outstanding (Diluted)
1,6271,6271,6221,6291,6131,606
Shares Change (YoY)
0.06%0.36%-0.47%1.01%0.42%16.59%
EPS (Basic)
1.171.140.821.321.540.83
EPS (Diluted)
1.171.140.821.311.540.82
EPS Growth
37.46%39.02%-37.41%-14.94%87.81%12.33%
Free Cash Flow
2,5601,7861,1438.93-672.27475.78
Free Cash Flow Per Share
1.571.100.700.01-0.420.30
Dividend Per Share
0.4800.4800.4700.4600.1600.150
Dividend Growth
2.13%2.13%2.17%187.50%6.67%50.00%
Gross Margin
48.35%48.11%44.47%45.76%43.45%42.69%
Operating Margin
15.48%14.90%11.85%13.53%11.86%11.49%
Profit Margin
7.95%7.74%5.23%8.70%11.12%6.41%
Free Cash Flow Margin
10.70%7.45%4.50%0.04%-3.01%2.31%
EBITDA
4,6824,5544,0154,1083,3723,020
EBITDA Margin
19.57%19.00%15.79%16.75%15.10%14.70%
D&A For EBITDA
977.83982.641,002788.75723.08659.23
EBIT
3,7053,5713,0143,3192,6492,361
EBIT Margin
15.48%14.90%11.85%13.53%11.86%11.49%
Effective Tax Rate
19.10%18.45%26.60%16.80%10.35%16.33%
Revenue as Reported
23,96223,96225,43524,52522,33820,549
Source: S&P Global Market Intelligence. Standard template. Financial Sources.